logo
  Join        Login             Stock Quote

ICU Medical (ICUI) To Discontinue Positive Displacement Technology Sale On FDA Concerns

 January 28, 2013 09:54 AM
 


(By Balaseshan) ICU Medical Inc. (NASDAQ: ICUI) said it will voluntarily discontinue U.S. distribution of the CLC2000 Positive Displacement Needlefree Connector effective April 30, 2013 due to concerns from theĀ U.S. Food and Drug Administration (FDA).

FDA concerns over the safety of positive displacement connectors coupled with increasing market demand for its newer technologies leads ICU Medical to discontinue U.S. sales of the 16-year-old CLC2000 technology, the company noted.

The CLC2000 will continue to be available for purchase in markets outside the United States. The company said it is facing sharply decreasing U.S. sales volumes as customers are switching to its newer, clinically superior needlefree connector technologies.

[Related -Stock Upgrades And Downgrades: AWK, BLK, ICUI, MGM, RAX, TSLA, VSAT]

In addition, FDA concerns regarding the safety of positive displacement needlefree connectors prompted the agency to require manufacturers to perform extensive post-market surveillance of these devices.

Given the decreasing demand for the CLC2000 and the ready availability of its clinically superior needlefree technology options, ICU Medical has chosen to remove the CLC2000 from the U.S. market rather than invest in an expensive study of an outdated technology.

The positive displacement technology has largely been replaced in the U.S. by clinicians choosing the neutral displacement features of the MicroClave Clear and, more recently, the anti-reflux technology of the Neutron Catheter Patency Device.

[Related -Stamps.Com Is A Standout Performer For The Crabtree Technology Model]

The Neutron Catheter Patency Device is the first and only FDA-cleared device shown to significantly reduce all types of reflux into a catheter and be cleared for use on all patients, including pediatric and immunocompromised patients.

ICUI is trading down 0.11% at $63.84 on Monday. The stock has been trading between $43.51 and $64.03 for the past 52 weeks.

iOnTheMarket Premium
Advertisement

Advertisement


Post Comment -- Login is required to post message
Name:  
Alert for new comments:
Your email:
Your Website:
Title:
Comments:
 

rss feed

Latest Stories

article imageOil Prices Stubbornly Resilient Around $50 a Barrel.

The majority opinion seems to be that oil prices will drop further, popular targets being $30 and $40, with read on...

article imageADP: US February Payrolls Continue To Grow, But At Slower Rate

Payrolls at US companies posted another respectable gain in February, advancing 212,000 over the previous read on...

article imageAre You Prepared For Negative Interest Rates?

Last Tuesday, all eyes were on Federal Reserve Chief Janet Yellen. In prepared testimony, she offered a few read on...

article imageGreek Problems Born from Socialism

Our weekly commentaries provide Euro Pacific Capital's latest thinking on developments in the global read on...

Advertisement
Popular Articles

Advertisement
Daily Sector Scan
Partner Center

Related Articles:

Volume Up As Week Ends; DHX And BJRI Breakout
More Articles on: Medical



Fundamental data is provided by Zacks Investment Research, and Commentary, news and Press Releases provided by YellowBrix and Quotemedia.
All information provided "as is" for informational purposes only, not intended for trading purposes or advice. iStockAnalyst.com is not an investment adviser and does not provide, endorse or review any information or data contained herein.
The blog articles are opinions by respective blogger. By using this site you are agreeing to terms and conditions posted on respective bloggers' website.
The postings/comments on the site may or may not be from reliable sources. Neither iStockAnalyst nor any of its independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. You are solely responsible for the investment decisions made by you and the consequences resulting therefrom. By accessing the iStockAnalyst.com site, you agree not to redistribute the information found therein.
The sector scan is based on 15-30 minutes delayed data. The Pattern scan is based on EOD data.